Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Rating Reaffirmed as “Buy” by TD Cowen

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)‘s stock had its “buy” rating reaffirmed by TD Cowen in a research report issued on Tuesday, Benzinga reports. They presently have a $15.00 target price on the stock. TD Cowen‘s price objective would indicate a potential upside of 86.94% from the stock’s previous close.

A number of other research firms have also issued reports on SENS. Mizuho reduced their price objective on Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating for the company in a research report on Wednesday, July 15th. Weiss Ratings lowered Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday. Wall Street Zen upgraded Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Finally, Barclays started coverage on Senseonics Holdings, Inc. Common Stock in a research report on Wednesday, October 7th. They set an “equal weight” rating and a $10.00 price target on the stock. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Up 7.3%

SENS traded up $0.54 during trading on Tuesday, hitting $8.02. The company had a trading volume of 356,719 shares, compared to its average volume of 662,362. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $10.64. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40. The company has a market cap of $335.40 million, a PE ratio of -3.58 and a beta of 1.02. The business has a 50-day moving average of $9.15 and a 200-day moving average of $7.16.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last issued its earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.08). The company had revenue of $14.48 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. As a group, analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.31 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Douglas Roeder acquired 13,953 shares of the stock in a transaction on Wednesday, August 19th. The shares were purchased at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the transaction, the director owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 4.70% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Integrated Wealth Concepts LLC purchased a new stake in shares of Senseonics Holdings, Inc. Common Stock during the second quarter worth $36,000. Kestra Advisory Services LLC bought a new position in Senseonics Holdings, Inc. Common Stock during the first quarter valued at approximately $68,000. The Manufacturers Life Insurance Company bought a new position in Senseonics Holdings, Inc. Common Stock during the second quarter valued at approximately $65,000. State of Wyoming acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $67,000. Finally, Cetera Investment Advisers acquired a new stake in Senseonics Holdings, Inc. Common Stock in the first quarter valued at approximately $85,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.